NASDAQ:RIBT - RiceBran Technologies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $3.58 -0.13 (-3.50 %) (As of 03/22/2019 04:00 PM ET)Previous Close$3.71Today's Range$3.56 - $3.7352-Week Range$1.45 - $3.87Volume43,000 shsAverage Volume62,639 shsMarket Capitalization$96.99 millionP/E RatioN/ADividend YieldN/ABeta0.69 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email RiceBran Technologies processes and markets healthy, natural, and nutrient dense products derived from raw rice bran. The company manufactures and distributes stabilized rice bran (SRB) in various granulations with other products and derivatives. It offers RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich derivative of RiBalance; and protein and protein/fiber blends under the ProRyza brand. The company serves natural food, food and animal nutrition manufacturers, wholesalers, and retailers in the United States, Brazil, and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was incorporated in 1998 and is headquartered in The Woodlands, Texas. Receive RIBT News and Ratings via Email Sign-up to receive the latest news and ratings for RIBT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Grain mill products Sub-IndustryN/A SectorConsumer Staples Current SymbolNASDAQ:RIBT Previous Symbol CUSIPN/A CIK1063537 Webwww.ricebrantech.com Phone602-522-3000Debt Debt-to-Equity RatioN/A Current Ratio5.96 Quick Ratio5.69Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$13.35 million Price / Sales7.27 Cash FlowN/A Price / Cash FlowN/A Book Value$0.85 per share Price / Book4.21Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-4,530,000.00 Net Margins-74.93% Return on Equity-45.57% Return on Assets-39.26%Miscellaneous Employees65 Outstanding Shares27,093,000Market Cap$96.99 million Next Earnings DateN/A OptionableNot Optionable RiceBran Technologies (NASDAQ:RIBT) Frequently Asked Questions What is RiceBran Technologies' stock symbol? RiceBran Technologies trades on the NASDAQ under the ticker symbol "RIBT." How were RiceBran Technologies' earnings last quarter? RiceBran Technologies (NASDAQ:RIBT) announced its quarterly earnings data on Thursday, August, 2nd. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.00. The company had revenue of $3.20 million for the quarter. RiceBran Technologies had a negative return on equity of 45.57% and a negative net margin of 74.93%. View RiceBran Technologies' Earnings History. What price target have analysts set for RIBT? 2 analysts have issued 1-year target prices for RiceBran Technologies' shares. Their forecasts range from $5.00 to $5.00. On average, they expect RiceBran Technologies' stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 39.7% from the stock's current price. View Analyst Price Targets for RiceBran Technologies. What is the consensus analysts' recommendation for RiceBran Technologies? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RiceBran Technologies in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for RiceBran Technologies. Has RiceBran Technologies been receiving favorable news coverage? News stories about RIBT stock have been trending neutral this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. RiceBran Technologies earned a news impact score of 0.5 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the company's share price in the near future. Who are some of RiceBran Technologies' key competitors? Some companies that are related to RiceBran Technologies include General Mills (GIS), Kellogg (K), Post (POST), Ingredion (INGR), Freshpet (FRPT) and Z-Trim (FBER). What other stocks do shareholders of RiceBran Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other RiceBran Technologies investors own include Micron Technology (MU), Corbus Pharmaceuticals (CRBP), Snap (SNAP), CHURCHILL CAP C/SH (CCC), Weibo (WB), Zynga (ZNGA), General Electric (GE), Sangamo Therapeutics (SGMO), Synergy Pharmaceuticals (SGYP) and Anavex Life Sciences (AVXL). Who are RiceBran Technologies' key executives? RiceBran Technologies' management team includes the folowing people: Mr. Brent Robert Rystrom, Pres, CEO & Director (Age 55)Mr. Dennis Dykes, Exec. VP, CFO & Corp. Sec. (Age 49)Dr. Rani Madhavapeddi Patel, Chief Science OfficerMs. Sherry Rhoads, VP of Compliance, Regulatory & External AffairsMr. Denny Lacy, Director of Sales Who are RiceBran Technologies' major shareholders? RiceBran Technologies' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (0.59%) and Dimensional Fund Advisors LP (0.59%). Company insiders that own RiceBran Technologies stock include Brent Robert Rystrom, David Goldman, Dennis Dykes, Grain Co Continental, Henk Hoogenkamp, Michael Goose, Robert D Smith and Robert S Bucklin. View Institutional Ownership Trends for RiceBran Technologies. Which institutional investors are buying RiceBran Technologies stock? RIBT stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP and Dimensional Fund Advisors LP. Company insiders that have bought RiceBran Technologies stock in the last two years include Brent Robert Rystrom, David Goldman, Dennis Dykes, Grain Co Continental, Henk Hoogenkamp, Michael Goose, Robert D Smith and Robert S Bucklin. View Insider Buying and Selling for RiceBran Technologies. How do I buy shares of RiceBran Technologies? Shares of RIBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is RiceBran Technologies' stock price today? One share of RIBT stock can currently be purchased for approximately $3.58. How big of a company is RiceBran Technologies? RiceBran Technologies has a market capitalization of $96.99 million and generates $13.35 million in revenue each year. RiceBran Technologies employs 65 workers across the globe. What is RiceBran Technologies' official website? The official website for RiceBran Technologies is http://www.ricebrantech.com. How can I contact RiceBran Technologies? RiceBran Technologies' mailing address is 1330 LAKE ROBBINS DRIVE SUITE 250, THE WOODLANDS TX, 77380. The company can be reached via phone at 602-522-3000 or via email at [email protected] MarketBeat Community Rating for RiceBran Technologies (NASDAQ RIBT)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 103 (Vote Outperform)Underperform Votes: 76 (Vote Underperform)Total Votes: 179MarketBeat's community ratings are surveys of what our community members think about RiceBran Technologies and other stocks. Vote "Outperform" if you believe RIBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RIBT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/23/2019 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?